The CDKN2A locus has been mentioned previously, but in the present context, it should be mentioned that, at the end of the last century, it was already known that the promoter of INK4A is hypermethylated in several cancers [165], favouring the alternative transcription of ARF. Here, CDKN2A is linked to cancer.